Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

SHPCX vs. BIB: which is better?

Bottom line

SHPCX vs BIB: the short answer

SHPCX (Health & Biotechnology Portfolio) and BIB (ProShares Ultra Nasdaq Biotechnology) are both mutual funds.

But BIB is far broader, holding 267 positions to 29 for SHPCX, so beyond the top names it adds exposure SHPCX doesn't have.

BIB is cheaper at 0.95% vs 3.6% — a difference of $265 a year per $10,000 invested.

Over five years, SHPCX returned +3.7% a year vs −1.0% for BIB (reporting dates differ).

Updated Nov 19, 2026

SHPCX vs BIB side by side

SHPCXBIB
TypeMutual fundETF
Fund familySaratoga AdvantageProShares
CategoryTechnology SectorTechnology Sector
Expense ratio3.6%0.95%
Annual cost per $10k$360$95
10-yr cost on $10k (prospectus)$3,862$1,401
Max front load0%None
12b-1 fee——
1-yr return−1.3%+59.3%
5-yr return (annualized)+3.7%−1.0%
10-yr return (annualized)+4.1%+1.4%
Best quarter+15.0%+56.2%
Worst quarter−13.0%−42.7%
Net assets (fund)$10.5M$73.7M
Number of holdings29267
Portfolio turnover22%29%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearSHPCXBIBDifference
2024−0.3%−10.0%+9.7%
2023−0.9%−1.3%+0.3%
2022+1.4%−28.6%+30.0%
2021+16.0%−5.9%+21.9%
2020+3.0%+39.7%−36.7%
2019+15.4%+45.5%−30.1%
2018−6.0%−24.4%+18.4%
2017+11.3%+40.8%−29.5%
2016−2.5%−44.2%+41.7%

Source: Fund prospectus bar charts

Holdings overlap

6 of SHPCX's top 25 holdings also appear in BIB's top 25.

Shared top holdings
HoldingSHPCXBIB
United Therapeutics Corp6.17%1.22%
Amgen Inc5.04%4.48%
Gilead Sciences Inc3.94%4.66%
Regeneron Pharmaceuticals Inc3.93%3.21%
Vertex Pharmaceuticals Inc3.36%4.65%
Incyte Corp2.89%0.97%

Source: SEC Form N-PORT

SHPCX top 10

  1. Cardinal Health Inc — 6.44%
  2. Jazz Pharmaceuticals Plc — 6.19%
  3. United Therapeutics Corp — 6.17%
  4. Amgen Inc — 5.04%
  5. Mckesson Corp — 4.90%
  6. Lantheus Holdings Inc — 4.64%
  7. Exelixis Inc — 4.55%
  8. Novartis Ag — 4.50%
  9. Cencora Inc — 4.33%
  10. Gilead Sciences Inc — 3.94%

BIB top 10

  1. N/a — 7.35%
  2. ProShares GENIUS Money Market ETF — 6.80%
  3. Gilead Sciences, Inc. — 4.66%
  4. Vertex Pharmaceuticals, Inc. — 4.65%
  5. Amgen, Inc. — 4.48%
  6. N/a — 3.94%
  7. N/a — 3.26%
  8. Regeneron Pharmaceuticals, Inc. — 3.21%
  9. N/a — 2.62%
  10. Alnylam Pharmaceuticals, Inc. — 2.01%

FAQ

What is the difference between SHPCX and BIB?
SHPCX (Health & Biotechnology Portfolio) and BIB (ProShares Ultra Nasdaq Biotechnology) are both mutual funds. But BIB is far broader, holding 267 positions to 29 for SHPCX, so beyond the top names it adds exposure SHPCX doesn't have.
Which is cheaper, SHPCX or BIB?
BIB has the lower expense ratio (0.95%).
Should I own both SHPCX and BIB?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.